Back

dr. F.Y.F.L. (Filip) de Vos

dr. F.Y.F.L. (Filip) de Vos

Assistant Professor - medical

Show full profile

Research Output (84)

Efficacy of the eHealth application Oncokompas, facilitating incurably ill cancer patients to self-manage their palliative care needs:A randomized controlled trial

Schuit Anouk S, Holtmaat Karen, Lissenberg-Witte Birgit I, Eerenstein Simone E J, Zijlstra Josée M, Eeltink Corien, Becker-Commissaris Annemarie, van Zuylen Lia, van Linde Myra E, Menke-van der Houven van Oordt C Willemien, Sommeijer Dirkje W, Verbeek Nol, Bosscha Koop, Tewarie Rishi Nandoe, Sedee Robert-Jan, de Bree Remco, de Graeff Alexander, de Vos Filip, Cuijpers Pim, Verdonck-de Leeuw Irma M Jul 2022, In: The Lancet Regional Health - Europe. 18 , p. 1-11

Prognostic significance of DNA methylation profiles at MRI enhancing tumor recurrence:a report from the EORTC 26091 TAVAREC trial

Draaisma Kaspar, Tesileanu C Mircea S, de Heer Iris, Klein Martin, Smits Marion, Reijneveld Jaap C, Clement Paul M, De Vos Filip, Wick Antje, Mulholland Paul, Taphoorn Martin, Weller Michael, Chinot Olivier L, Kros Johan M, Verschuere Tina, Coens Corneel, Golfinopoulos Vassilis, Gorlia Thierry, Idbaih Ahmed, Robe Pierre A, van den Bent Martin J, French Pim J 16 Mar 2022, In: Clinical cancer research : an official journal of the American Association for Cancer Research. 28 , p. 2440-2448 9 p.

Landscape of driver gene events, biomarkers, and druggable targets identified by whole-genome sequencing of glioblastomas

van de Geer Wesley S, Hoogstrate Youri, Draaisma Kaspar, Robe Pierre A, Bins Sander, Mathijssen Ron H J, French Pim, van de Werken Harmen J G, de Vos Filip Y F 21 Jan 2022, In: Neuro-oncology advances. 4

Results from a First-in-Human Phase I Study of Siremadlin (HDM201) in Patients with Advanced Wild-Type TP53 Solid Tumors and Acute Leukemia

Stein Eytan M, DeAngelo Daniel J, Chromik Jörg, Chatterjee Manik, Bauer Sebastian, Lin Chia-Chi, Suarez Cristina, De Vos Filip, Steeghs Neeltje, Cassier Phillippe A, Tai David, Kiladjian Jean-Jacques, Yamamoto Noboru, Mous Rogier, Esteve Jordi, Minami Hironobu, Ferretti Stéphane, Guerreiro Nelson, Meille Christophe, Radhakrishnan Rajkumar, Pereira Bernard, Mariconti Luisa, Halilovic Ensar, Fabre Claire, Carpio Cecilia 3 Dec 2021, In: Clinical cancer research : an official journal of the American Association for Cancer Research. 28 , p. 870-881 12 p.

Dabrafenib plus trametinib in patients with BRAFV600E-mutant low-grade and high-grade glioma (ROAR):a multicentre, open-label, single-arm, phase 2, basket trial

Wen Patrick Y, Stein Alexander, van den Bent Martin, De Greve Jacques, Wick Antje, de Vos Filip Y F L, von Bubnoff Nikolas, van Linde Myra E, Lai Albert, Prager Gerald W, Campone Mario, Fasolo Angelica, Lopez-Martin Jose A, Kim Tae Min, Mason Warren P, Hofheinz Ralf-Dieter, Blay Jean-Yves, Cho Daniel C, Gazzah Anas, Pouessel Damien, Yachnin Jeffrey, Boran Aislyn, Burgess Paul, Ilankumaran Palanichamy, Gasal Eduard, Subbiah Vivek 24 Nov 2021, In: LANCET ONCOLOGY. 23 , p. 53-64 12 p.

Added Value of Cognition in the Prediction of Survival in Low and High Grade Glioma

van Kessel Emma, Schuit Ewoud, Huenges Wajer Irene M C, Ruis Carla, De Vos Filip Y F L, Verhoeff Joost J C, Seute Tatjana, van Zandvoort Martine J E, Robe Pierre A, Snijders Tom J 18 Nov 2021, In: Frontiers in Neurology. 12 , p. 1-11

The EGFRvIII transcriptome in glioblastoma, a meta-omics analysis

Hoogstrate Youri, Ghisai Santoesha A, de Wit Maurice, de Heer Iris, Draaisma Kaspar, van Riet Job, van de Werken Harmen J G, Bours Vincent, Buter Jan, Vanden Bempt Isabelle, Eoli Marica, Franceschi Enrico, Frenel Jean-Sebastien, Gorlia Thierry, Hanse Monique C, Hoeben Ann, Kerkhof Melissa, Kros Johan M, Leenstra Sieger, Lombardi Giuseppe, Lukacova Slávka, Robe Pierre A, Sepulveda Juan M, Taal Walter, Taphoorn Martin, Vernhout René M, Walenkamp Annemiek M E, Watts Colin, Weller Michael, de Vos Filip Y F, Jenster Guido W, van den Bent Martin, French Pim J 5 Oct 2021, In: Neuro-Oncology. 24 , p. 429-441 13 p.

Comparison of 2-Hydroxyglutarate Detection With sLASER and MEGA-sLASER at 7T

Shams Zahra, van der Kemp Wybe J M, Emir Uzay, Dankbaar Jan Willem, Snijders Tom J, de Vos Filip Y F, Klomp Dennis W J, Wijnen Jannie P, Wiegers Evita C 7 Sep 2021, In: Frontiers in Neurology. 12 , p. 1-10

CONVENTIONAL MRI CRITERIA DIFFERENTIATE TRUE TUMOUR PROGRESSION FROM TREATMENT-INDUCED EFFECTS IN IRRADIATED WHO GRADE 3 AND 4 GLIOMAS

Flies C. M., van Leuken K. H., Verhoeff J. J. C., de Vos F. Y. F., Seute T., Robe P. A., Hendrikse J., Witkamp T. D., Dankbaar J. W., Snijders T. J. Sep 2021, In: Neuro-Oncology. 23 , p. ii41-ii41

Evaluation of the Khorana, PROTECHT, and 5-SNP scores for prediction of venous thromboembolism in patients with cancer

Guman Noori A M, van Geffen Roos J, Mulder Frits I, van Haaps Thijs F, Hovsepjan Vahram, Labots Mariette, Cirkel Geert A, de Vos Filip Y F L, Ten Tije Albert J, Beerepoot Laurens V, Tjan-Heijnen Vivianne C G, van Laarhoven Hanneke W M, Hamberg Paul, Vulink Annelie J E, Los Maartje, Zwinderman Aeilko H, Ferwerda Bart, Lolkema Martijn P J K, Steeghs Neeltje, Büller Harry R, Kamphuisen Pieter W, van Es Nick 19 Aug 2021, In: Journal of thrombosis and haemostasis : JTH. 19 , p. 2974-2983 10 p.

Thank you for your review!

Has this information helped you?

Please tell us why, so that we can improve our website.

Working at UMC Utrecht

Contact

Emergency?

Directions

Appointments

Practical

umcutrecht.nl maakt gebruik van cookies

Deze website maakt gebruik van cookies Deze website toont video’s van o.a. YouTube. Dergelijke partijen plaatsen cookies (third party cookies). Als u deze cookies niet wilt kunt u dat hier aangeven. Wij plaatsen zelf ook cookies om onze site te verbeteren.

Lees meer over het cookiebeleid

Akkoord Nee, liever niet